We propose a novel and exciting hypothesis?based on literature and our own pilot data?that neuronal injury stimulates astrocyte activation via thrombin and its receptor PAR-1, and the resulting astrocyte response to injury yields transmissible paracrine protection of neurons. Together, neurons, astroctyes, endothelial cells, pericytes, and oligodendroglia comprise the neurovascular unit, or NVU. Data generated from the several aims will yield insights into the mechanism for the well-documented phenomenon of pre-conditioning; will provide considerable insights into the mechanisms of differential vulnerability to cerebral injury; and would likely yield treatment options for stroke patients. To accomplish the aims, we are creating novel conditional knock-out mice that will provide research tools to the broader research field. The previous award, R01 NS075930, covered 8/15/2011 to 03/31/2015 and involved 4 aims. All proposed work has been completed and published or under review. The data from our prior award has already influenced stroke care significantly, in the form of two funded clinical trials. However, our prior data could not fully explain the known differences among the elements of the NVU, specifically, that astrocytes and endothelial cells tolerate ischemia better than neurons. What is the mechanism of thrombin-mediated pre-conditioning, and can we relate that mechanism to other forms of pre- and peri-conditioning? Why does the brain contain prothrombin mRNA and protein and what purpose could be served by thrombin activation in brain? Could we derive insights about the response of the brain to injury, and specifically explore the cell-subtype interactions during injury among astrocytes, neurons, pericytes, oligodendroglia, and endothelial cells? To answer these questions, and to address the central hypothesis of the present award application, we added significant new models to our repertoire, and generated pilot data speaking to the feasibility and novelty of the proposed new specific aims.
We propose a novel and exciting hypothesis that neuronal injury stimulates astrocyte activation via thrombin and its receptor PAR1, and the resulting astrocyte response to injury yields transmissible paracrine protection of neurons. Our work will yield insights into the mechanism of pre-conditioning, into the mechanisms of differential vulnerability to cerebral injury, and would likely yield treatment options for stroke patients.
|Li, You; Shen, Xiao Z; Li, Liang et al. (2017) Brain Transforming Growth Factor-? Resists Hypertension Via Regulating Microglial Activation. Stroke 48:2557-2564|
|Shen, Xiao Z; Li, You; Li, Liang et al. (2015) Microglia participate in neurogenic regulation of hypertension. Hypertension 66:309-16|
|Lyden, Patrick (2015) Why don't more patients receive intravenous rt-PA for acute stroke? Expert Rev Neurother 15:571-4|
|Lyden, Patrick; Pereira, Benedict; Chen, Bo et al. (2014) Direct thrombin inhibitor argatroban reduces stroke damage in 2 different models. Stroke 45:896-9|
|Rajput, P S; Lyden, P D; Chen, B et al. (2014) Protease activated receptor-1 mediates cytotoxicity during ischemia using in vivo and in vitro models. Neuroscience 281:229-40|
|Chen, Bo; Van Winkle, Jessica A; Lyden, Patrick D et al. (2013) PHLPP1 gene deletion protects the brain from ischemic injury. J Cereb Blood Flow Metab 33:196-204|
|Van Winkle, Jessica A; Chen, Bo; Lei, I-Farn et al. (2013) Concurrent middle cerebral artery occlusion and intra-arterial drug infusion via ipsilateral common carotid artery catheter in the rat. J Neurosci Methods 213:63-9|
|Wang, Yaoming; Zhao, Zhen; Chow, Nienwen et al. (2013) Activated protein C analog protects from ischemic stroke and extends the therapeutic window of tissue-type plasminogen activator in aged female mice and hypertensive rats. Stroke 44:3529-36|
|Chen, Bo; Friedman, Beth; Whitney, Michael A et al. (2012) Thrombin activity associated with neuronal damage during acute focal ischemia. J Neurosci 32:7622-31|